JESSICA WARD: Open Payments
NPI 1407212715 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 15 payments from 7 companies in 2025. Trend: 2023 $1,113 · 2024 $730 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $146 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| MML US, Inc. | 2 | $29 |
| Saluda Medical Americas, Inc. | 1 | $24 |
| Valinor Pharma, LLC | 1 | $20 |
| SPR Therapeutics, Inc | 1 | $17 |
| Native Surgical, LLC | 1 | $15 |
Products named: RELISTOR, XTAMPZA, ReActiv8, Evoke, MOVANTIK, SPRINT PNS System.
Industry payments across MD — which companies pay providers there.
